Alzheimer's disease statistics
If you've ever known someone who was afflicted with Alzheimer's disease, you know exactly how devastating the disease can be. It's a terrible problem that can cause a person to lose the abilities to do even the most basic of activities that everyday life demands, and it can be a trying issue for the patient and their loved ones alike. In this article, we'll relay to you some Alzheimer's disease statistics to help you to understand exactly how prevalent the disease is.
- According to some studies, Alzheimer's disease is present in roughly 4.5 million people in America alone. This is a pretty large number, and unfortunately, the rate of people with the disease has gone up more than double since the year 1980. At the current rate of growth of the disease, projections for the year 2050 state that as many as 11.3 million to 16 million people may face the disease. Medical advancements may be able to keep this number from coming true, however; research has shown that if a treatment were to come out for the disease which caused the onset to be delayed for 5 years, the rate could actually drop to fifty percent of its current rate by the year 2050.
- In addition to all of the mental suffering that one may go through when a loved one has Alzheimer's, there is also a lot of financial worry that the disease can cause. The total cost of treating Alzheimer's patients in America, per year, is projected to be over one hundred billion dollars. The disease also causes much woe to businesses, which lose roughly sixty one billion dollars per year due to health care costs and lost productivity due to workers that have had to take time off.
- On an individual basis, the costs for caring for an Alzheimer's patient can be devastating. The average cost of care for the lifetime of someone with the disease is about one hundred and seventy four thousand dollars. That statistic is based off of the facts that around seven out of ten Alzheimer's patients live at home and rely principally on the care of loved ones. If the patient were to be in a nursing home for the duration of the disease, the cost would be much higher: the average cost of a nursing home in America, per year, is forty two thousand dollars.
- In the fight for better Alzheimer's treatment, many have given their time and efforts to beating the disease. In the year 2005, the American government has spent six hundred and forty seven million dollars towards finding better treatment for the disease. One of the leading Alzheimer's organizations, the Alzheimer's Association, has given over one hundred and eighty five million dollars to research studies in order to beat the disease.
Now that you know more about what is being done to fight the disease and exactly what kind of financial situation those who have a loved one with Alzheimer's face, you can have a greater understanding of the problem. If you can, help contribute to research to fight the disease. One in three people know someone who has been afflicted with Alzheimer's, and we need to do all that we can to decrease that rate.
Alzheimer's Disease on the Web
Famous 1848 Case Of A Man Who Survived A Terrible Brain Injury Has Modern Parallel
Poor Phineas Gage. In 1848, the supervisor for the Rutland and Burlington Railroad in Vermont was using a 13-pound, 3-foot-7-inch rod to pack blasting powder into a rock when he triggered an explosion that drove the rod through his left cheek and out of the top of his head. As reported at the time, the rod was later found, "smeared with blood and brains... |
New Clues On How ApoE4 Affects Alzheimer's Risk
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the brain... |
Obama's Grand Plan To Cure Alzheimer's
Obama's healthcare goals have been controversial at best, and although anti-smoking campaigns and other public health and safety awareness drives have been successful, it's always somewhat dubious when government starts creating grand plans and lofty goals... |
Dementia Sufferers More Likely To Die At Home Than In Nursing Homes
A new study from the Regenstrief Institute and Indiana University has found that, at time of death, individuals with dementia are more likely to be living at home than in a nursing home. This contradicts the commonly held view that most individuals with dementia in the United States eventually move to nursing homes and die there... |
Could A Compound Found In Red Wine And Red Grapes Change The Course Of Alzheimer's Disease?
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study... |
Memory Improved In Amnestic Mild Cognitive Impairment By Reducing Excess Brain Activity
Research published by Cell Press in the journal Neuron, describes a potential new therapeutic approach for improving memory and modifying disease progression in patients with amnestic mild cognitive impairment. The study finds that excess brain activity may be doing more harm than good in some conditions that cause mild cognitive decline and memory impairment... |
Middle Aged And Elderly With Depression Have Higher Risk Of Dementia
A report in the May issue of Archives of General Psychiatry draws a link between people in mid-life and late-life, suffering from depression and the possibility of them developing dementia. More than five million people in the US alone suffer from Alzheimer's disease, and the health care costs run at a staggering $172 Billion. Deborah E. Barnes, Ph.D., M.P.H... |
Memantine Improves Some Alzheimer's Symptoms But Has No Effect On Agitation
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway. This is the first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients... |
Discovery Of Potential Trigger For Alzheimer's Disease
A highly toxic beta-amyloid - a protein that exists in the brains of Alzheimer's disease victims - has been found to greatly increase the toxicity of other more common and less toxic beta-amyloids, serving as a possible "trigger" for the advent and development of Alzheimer's, researchers at the University of Virginia and German biotech company Probiodrug have discovered... |
Too Early To Promote Smell Test For Alzheimer's
A study published online in The Laryngoscope reveals that current studies do not support the use of olfactory identification tests (smell tests) for predicting Alzheimer's dementia. Alzheimer's is a progressive disease that causes loss of brain function and is the most common cause of dementia. The disease is expected to double every 20 years through the year 2040... |
Helping Patients With Dementia Live Well
Care Services Minister Paul Burstow unveiled a range of new design prototypes at the Design Council that can help people with dementia to live well, which included a fragrance-release system designed to stimulate appetite, specially-trained 'guide dogs for the mind' and an intelligent wristband that supports people with dementia to stay active safely... |
Strong Support Uncovered For Once-Marginalized Theory On Parkinson's Disease
University of California, San Diego scientists have used powerful computational tools and laboratory tests to discover new support for a once-marginalized theory about the underlying cause of Parkinson's disease. The new results conflict with an older theory that insoluble intracellular fibrils called amyloids cause Parkinson's disease and other neurodegenerative diseases... |
'Use It Or Lose It' - Protecting Your Brain
The findings of a new study suggest that the protective effects of an active cognitive lifestyle arise through multiple biological pathways. For some time researchers have been aware of a link between what we do with our brains and the long term risk for dementia. In general, those who are more mentally active or maintain an active cognitive lifestyle throughout their lives are at lower risk... |
|